Merck (MRK) reportedly in talks to buy Revolution Medicines (RVMD), according to FT; deal not finalized

Merck's reported discussions to acquire Revolution Medicines reflect strategic expansion in the biotechnology sector.

Newsquawk StaffPublished On the live feed at 3 more headlines followed before this page went public
Newsquawk headlinesUTC

US President Trump says strike on Nigeria could be a one-off, or repeated if Christians are killed

Denmark and Greenland envoys will reportedly meet at the White House, according to AP; date not disclosed

Merck (MRK) reportedly in talks to buy Revolution Medicines (RVMD), according to FT; deal not finalized

Former NIH Director Green to join Illumina (ILMN) as Chief Medical Officer, via Endpoint News

US FX WRAP: Dollar boosted by labour data ahead of NFP; Antipodes lag amid pressure in metals

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

While the deal is not yet finalized, it highlights Merck's intent to enhance its pipeline and competitive edge, which could have positive implications for its stock and possibly influence sentiment in the broader pharmaceuticals space. Watch for market reactions based on any developments or finalization of the talks.

Related headlines

The whole workspace, free to try.

Try it free